Inverse Relationship Between Serum Small Dense LDL Cholesterol Levels and Kidney Stone Incidence: Findings from Two Distinct Cross-Sectional Studies - Top-Institutions - MDSpire

Inverse Relationship Between Serum Small Dense LDL Cholesterol Levels and Kidney Stone Incidence: Findings from Two Distinct Cross-Sectional Studies

  • By

  • Yangyang Zhang

  • Haibo Qin

  • Junping Yang

  • Xudong Shen

  • Zongyao Hao

  • Chaozhao Liang

  • April 29, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Nephrology
    • Urology
    • Lipidology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Nephrology
    • Urology
    • Cardiovascular and Metabolic Research

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Nephrology
    • Urology
    • Epidemiology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Nephrology
    • Urology
    • Metabolic Disease Research

  • #5

    Peking University First Hospital
    Peking University First Hospital

    Beijing, China

    Key Differentiators

    • Nephrology
    • Urology
    • Epidemiology

Original Source(s)

Inverse Relationship Between Serum Small Dense LDL Cholesterol Levels and Kidney Stone Incidence: Findings from Two Distinct Cross-Sectional Studies

  • by Yangyang Zhang, Haibo Qin, Junping Yang, Xudong Shen, Zongyao Hao, Chaozhao Liang

  • April 29, 2026

Related Content

Editorial: Polycystic ovarian syndrome in adolescence

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

Machine Learning–Based risk stratification for in-hospital mortality in ICU patients with cardiovascular diseases and diabetes